Reneuron Share Discussion Threads

[dickbush] 16/1/2014 12:36

I've searched but can't find a connection between Dr MacLaren and Reneuron. It looks like a totally separate effort.

[waterloo01] 16/1/2014 11:59

Hyper, don't think so, they are still focused on strokes but it might be from their cell line? but I'm not nearly as well informed here as I am elsewhere!

"Our ReN003 programme for blindness-causing diseases of the retina is partnered with the Schepens Eye Research Institute Massachusetts Eye and Ear (an affiliate of Harvard Medical School in Boston, USA). This programme is initially focused on retinitis pigmentosa, a disease leading to progressive loss of vision due to loss of the photoreceptor cells found in the retina. A number of pre-clinical studies are underway and planned over the next year ahead of an initial UK and/or US clinical trial.
Ultimately, we expect to realise value by out-licensing our stem cell therapies to commercial development partners at the appropriate points in their respective development programmes."

[norbus] 31/12/2013 08:12

Coming to EU soon: Beats stem cells

New Model Healthcare for USA when unaffordable care act comes in

[norbus] 20/12/2013 12:50

Prozac works well enough

Only an Idiot can think a free BB like this has the slightest effect on a share like this

[stewart_25] 19/12/2013 14:05

interesting rise back up... Would love to see some great news as this share is depressing even though so much positive potential is there - don't want to jump out too early, but conversely don't want to get bogged down by serial negative drivel posters (yes they know who they are)

[norbus] 18/12/2013 15:03

Intriguing drop. Year end? Fund selling off 2.5p placing price for some bottom line support . Only thing making sense.

[rocket fuel] 05/12/2013 10:37

sitiain, they don't have £25m in the bank! they will have £22m as of the end of this month.
they raised £25.35m
c£2m went to cenkos for the placing (nice work if you can get it)
over 500k burn per month on that cash since 1st oct (previous cash ran out end of sep)
burn set to at least double and more when they get patients in to clinic sometime next year (probably spring if you are lucky)

will probably have c£20m left when 001 trials resume and 009 start (lets say in may 2014) if they then decide to throw 003 in to the mix further down the line i reckon that £20m will take them to around summer 2015 before the begging bowl comes out again and i doubt they will get anymore cash calls off AIM as they will have burnt close to £100m of mug punter money by then.

[sitiain] 05/12/2013 05:50

RF
if you think 63 mio pounds is too high, even with 25 mio in the bank
go and have a look at CELLDEX THERAPEUTICS CLDX
Market cap 2.2 bio dollars.
Go on their message board and bore them to death instead of us.

[morriseyme] 04/12/2013 11:19

o/t look at the PYC news just out.

PYC Market cap £3m and signed SIGNIFICANT contract with MAJOR PHARMA!

[masingi] 04/12/2013 09:41

Rocket Fuel- Phase 3 trials are expensive, but the rewards should they be successful with this therapy are enormous; a game-changer in the medical market. Success in phase I/II will stimulate considerable interest in the company and it is at that point where marketing partners with cash will be found to fund the phase III trials, or interest by big pharma in a buy-out. This won't happen before completion of successful phase II trials.

Worrying about how phase III trials will be funded before the phase II trials have been concluded is putting the cart before the horse, somewhat.

The gamble here is whether the phase II trials will be successful. If they are, the company will be sitting on some extremely valuable property, if not, game over.

If you think the phase II trials will fail, short the stock.
If you think the phase II trials will succeed, go long.
Everything else is just puff and nonsense.

Place your bets....

[rocket fuel] 03/12/2013 14:34

Norbus they definately cannot afford to fund phase three from existing cash flow. I doubt they will stretch existing cash to complete phase2 001 if they start 009,003, osis and whatever else thrown in on top.

[stewart_25] 03/12/2013 14:32

its amazing every time that blundering idiot posts the share price drops. Is anyone actually taking notice of him or has he just got impeccable timing lol...

[deltar] 03/12/2013 14:30

RF - yawn.

[masingi] 03/12/2013 12:02

Oh God, has Robbing Fool opened a short again?

[norbus] 03/12/2013 10:59

r f

I am wondering what your game is now. Three years cash in hand with many events shaping positive progress, allow a higher valuation should more money be needed.
As much as I regard management with distaste, I will cheer loudly if they advance the treatment of stroke, let along the arterial disease. I think the next raise will be at >10p

[rocket fuel] 03/12/2013 10:39

I'm talking long term end game here jw. I can just smell a wrong un here. you will always get the odd spike on news where the unknowing gullible herd wade in, but the stale bulls will take it as an opportunity to exit.
I just cannot see how they can sustain a £67m mkt cap with no sign of commercial revenue for at least 7-10yrs (if all goes well that is) and they have just £22.5m burn money left to get them there. (burning at a rate of 500k p/m and soon to double or triple no doubt whenever trials start and resume)
remember they have burnt c£50m to date here in the 8yrs since ipo and they are just at the analysing data stage of phase1 ReN001

[jwoolley] 03/12/2013 10:08

The fact of the matter rocket fuel....you started deramping this share at 2p saying it was going to 1p or lower and you could of doubled your money if you had invested at the start.....missed opportunity old boy!!!